Skip to content
Screener

Bio-Techne TECH Equity Method Investment, Realized Gain (Loss) on Disposal

Equity Method Investment, Realized Gain (Loss) on Disposal at other companies

TMC the metals company Inc. logo
TMC the metals company Inc.TMC
-$3M-8,466%
TEC
Bio-TechneTECH
-$739K-25.5%
Vestis logo
VestisVSTS
$0
Lesaka Technologies, Inc. logo
Lesaka Technologies, Inc.LSAK
$0
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
$290.08K+25.9%
Crown Holdings logo
Crown HoldingsCCK
$0-100%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemNine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
Costs recognized on sale of acquired inventory554
Deferred income taxes8,045(18,825)
Stock-based compensation expense36,13536,283
(Gain) Loss on equity method investment335169
(Gain) Loss on investments2,334
Asset impairment restructuring3,2539,961
Leases, net(2,619)502
Recovery of assets held-for-sale(6,789)(3,655)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's equity method investment, realized gain (loss) on disposal?
Bio-Techne (TECH) reported equity method investment, realized gain (loss) on disposal of -$739K in Q1 2026.
How has Bio-Techne's equity method investment, realized gain (loss) on disposal changed year-over-year?
Bio-Techne's equity method investment, realized gain (loss) on disposal decreased by 25.5% year-over-year, from -$589K to -$739K.
What is the long-term trend for Bio-Techne's equity method investment, realized gain (loss) on disposal?
Over 2 years (2023 to 2025), Bio-Techne's equity method investment, realized gain (loss) on disposal has grown at a -9.4% compound annual growth rate (CAGR), from -$1.14M to $938K.
What does equity method investment, realized gain (loss) on disposal mean?
This captures the realized gain or loss when the company disposes of an investment accounted for under the equity method. It reflects the cash impact of exiting a strategic partnership or minority stake in another entity.

Ask your AI about Bio-Techne's equity method investment, realized gain (loss) on disposal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude